Product Name | AG1296 |
Description |
PDGFR kinase inhibitor |
Purity | >98% (TLC) |
CAS No. | 146535-11-7 |
Molecular Formula | C16H14N2O2 |
Molecular Weight | 266.3 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | Soluble in DMSO or dichloromethane |
Source | Synthetic |
Appearance | Off-white to brownish solid |
SMILES | C1=C(OC)C(=CC2=NC=C(N=C12)C3=CC=CC=C3)OC |
InChI | InChI=1S/C16H14N2O2/c1-19-15-8-12-13(9-16(15)20-2)18-14(10-17-12)11-6-4-3-5-7-11/h3-10H,1-2H3 |
InChIKey | QNOXYUNHIGOWNY-UHFFFAOYSA-N |
Safety Phrases |
Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
Cite This Product | AG1296 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-426) |
Alternative Names | Tyrphostin AG 1296, 6,7-Dimethoxy-3-phenylquinoxaline, 6,7-Dimethoxy-2-phenylquinoxaline |
Research Areas | Apoptosis, Cancer, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors |
PubChem ID | 2049 |
Scientific Background | AG-1296 is a potent and specific inhibitor of PDGF receptor tyrosine kinase. AG-1296 is cell-permeable. |
References | 1. Strutz F., et al. (2001) Kidney Int. 59(2): 579–592. |
Reviews
There are no reviews yet.